U.S. Markets closed

KaloBios Pharmaceuticals, Inc. (KBIO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.25-0.05 (-2.17%)
At close: 3:01PM EDT
People also watch
Interactive chart
Previous Close2.30
Bid0.00 x
Ask0.00 x
Day's Range2.20 - 2.25
52 Week Range1.90 - 5.21
Avg. Volume6,203
Market Cap33.7M
PE Ratio (TTM)-0.81
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Forbes3 months ago

    Rare Diseases Patients Need More Than Miracles And Trumpcare

    Rare Disease Week was rapidly followed by more proposals to gut the ACA healthcare and the FDA, immigration and travel bans which will decimate research and healthcare (as well as being needless and cruel), and reduce research budgets. How does this help patients?

  • Investopedia8 months ago

    KaloBios Plans Big In The Post-Shkreli Era (KBIO)

    Martin Shkreli’s departure and sale of his stake have allowed KaloBios to focus on a turnaround

  • We're sorry this is all we were able to find about this topic.